Measuring the Informative and Persuasive Roles of Detailing on Prescribing Decisions

References

• Ackerberg D. A. Empirically distinguishing informative and prestige effects of advertising. RAND J. Econom. (2001) 32(2):100–118Crossref, Google Scholar
• Berndt E., Bui L. T., Reiley D. H., Urban G. L. The role of marketing, product quality, and price competition in the growth and composition of the U.S. anti-ulcer drug industry. The Economics of New Goods, NBER Studies in Income and Wealth (1997) 58(University of Chicago Press, Chicago) 277–322Google Scholar
• Bernitz U. Brand differentiation between identical products: An analysis from a consumer law viewpoint. J. Consumer Policy (1981) 5(1–2):21–38Crossref, Google Scholar
• Birkett D. J. Generics—equal or not? Australian Prescriber (2003) 26(4):85–87Crossref, Google Scholar
• Byzalov D., Shachar R. The risk reduction role of advertising. Quant. Marketing Econom. (2004) 2(4):283–320Crossref, Google Scholar
• Ching A. T. A dynamic oligopoly structural model for the prescription drug market after patent expiration. Internat. Econom. Rev. (2010a) 51(4):1175–1207Crossref, Google Scholar
• Ching A. T. Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration. Internat. J. Indust. Organ. (2010b) 28(6):619–638Crossref, Google Scholar
• Ching A. T., Ishihara M. The effects of detailing on prescribing decisions under quality uncertainty. Quant. Marketing Econom. (2010) 8(2):123–165Crossref, Google Scholar
• CurrentPartneringCo-promotion and Co-marketing Agreements in Pharma, Biotech, and Diagnostics (2009) (CurrentPartnering, a division of Wildwood Ventures Limited, York, UK) Google Scholar
• DeGroot M. H.Optimal Statistical Decisions (1970) (McGraw-Hill, New York) Google Scholar
• Economist, The Pushing pills: Marketing drugs to doctors is turning into a tricky business. (2003) February 13). http://www.economist.com/node/1580138Google Scholar
• Erdem T., Keane M. P. Decision making under uncertainty: Capturing dynamic brand choice processes in turbulent consumer goods markets. Marketing Sci. (1996) 15(1):1–20Link, Google Scholar
• Hurwitz M. A., Caves R. E. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. J. Law Econom. (1988) 31(2):299–320Crossref, Google Scholar
• Iizuka T. Physician agency and adoption of generic pharmaceuticals. (2011) . Working paper, University of Tokyo, TokyoCrossref, Google Scholar
• Keane M. P. Structural vs. atheoretic approaches to econometrics. J. Econometrics (2010) 156(1):3–20Crossref, Google Scholar
• Lado N., Licandro O., Perez F. How brand names affect the price setting of car makers producing twin cars? (2003) . Working paper, European University Institute, Florence, ItalyGoogle Scholar
• Leffler K. Persuasion or information? The economics of prescription drug advertising. J. Law Econom. (1981) 24(1):45–74Crossref, Google Scholar
• Mehta N., Chen X. (Jack), Narasimhan O. Informing, transforming, and persuading: Disentangling the multiple effects of advertising on brand choice decisions. Marketing Sci. (2008) 27(3):334–355Link, Google Scholar
• Narayanan S., Manchanda P. Heterogeneous learning and the targeting of marketing communication for new products. Marketing Sci. (2009) 28(3):424–441Link, Google Scholar
• Narayanan S., Manchanda P., Chintagunta P. K. Temporal differences in the role of marketing communication in new product categories. J. Marketing Res. (2005) 42(3):278–290Crossref, Google Scholar
• Nerlove M., Arrow K. J. Optimal advertising policy under dynamic conditions. Economica (1962) 29(114):129–142Crossref, Google Scholar
• Rizzo J. Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs. J. Law Econom. (1999) 42(1):89–116Crossref, Google Scholar
• Saunders J. A., Watt F. A. W. Do brand names differentiate identical industrial products. Indust. Marketing Management (1979) 8(2):114–123Crossref, Google Scholar
• Sullivan M. W. How brand names affect the demand for twin automobiles. J. Marketing Res. (1998) 35(2):154–165Crossref, Google Scholar
• Tu K., Campbell N. R. C., Duong-Hua M., McAlister F. A. Hypertension management in the elderly has improved: Ontario prescribing trend, 1994 to 2002. Hypertension (2005) 45(6):1113–1118Crossref, Google Scholar